Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6352)
All Articles published online
|
Publishing Process of This Article
|
Jul 26, 2021 (publication date) through Jul 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Long HY, Huang TY, Xie XY, Long JT, Liu BX. Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis. World J Clin Cases 2021; 9(21): 5754-5768 [PMID: 34368295 DOI: 10.12998/wjcc.v9.i21.5754] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i21/5754.htm |
| Number | Citing Articles |
| 1 |
Hao-Huan Tang, Ming-Qing Zhang, Zi-Chen Zhang, Chen Fan, Yong Jin, Wei-Dong Wang. The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapies for the Treatment of Intermediate and Advanced Hepatocellular Carcinoma Unsuitable for Transarterial Chemoembolization. Journal of Hepatocellular Carcinoma 2023; : 2211 doi: 10.2147/JHC.S441024
|
| 2 |
Tinotenda Blessing Madzikatire, Yunfeng Shan. Case report and literature analysis: solitary HCC- recurrence in the right maxillary sinus after curative resection. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1279126
|
| 3 |
Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Moon Seok Choi. Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy. Journal of Liver Cancer 2024; 24(2): 243 doi: 10.17998/jlc.2024.05.26
|
| 4 |
Leonardo Gomes da Fonseca, Raphael L C Araujo. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities. World Journal of Gastroenterology 2022; 28(28): 3573-3585 doi: 10.3748/wjg.v28.i28.3573
|
| 5 |
Xun Zhuang, Chunrong Wang, Zhenghui Ge, Mengjie Wu, Mengjiao Chen, Zhen Chen, Jianghong Hu. MICAL1 Mediates TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma by Activating Smad2/3. Cell Biochemistry and Biophysics 2025; 83(2): 2589 doi: 10.1007/s12013-025-01668-8
|
| 6 |
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, Ali Mohammed Obayes, Zafar Aminov, Fahad Alsaikhan, Andrés Alexis Ramírez-Coronel, Pushpamala Ramaiah, Nahla A. Tayyib, Xuanming Luo. Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches. Environmental Research 2023; 228: 115767 doi: 10.1016/j.envres.2023.115767
|
| 7 |
Yesen Li, Yanjie Wang, Yaoxuan Wang, Jinxiong Huang, Zhide Guo. Development and Evaluation of 68Ga-Labeled TMTP1-Based Cyclic Peptide Probes for Targeting Hepatocellular Carcinoma. Molecular Pharmaceutics 2025; 22(4): 1901 doi: 10.1021/acs.molpharmaceut.4c01123
|
| 8 |
Junjun Jia, Jia Luo, Bei Zou, Meibao Feng, Li Liu, Songfeng Yu, Shusen Zheng, Jun Yu. Non-iatrogenic implantation of cutaneous metastasis from hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(4): 1513 doi: 10.1007/s00432-022-04030-0
|
| 9 |
Jason K. Wong, Howard J. Lim, Vincent C. Tam, Kelly W. Burak, Laura A. Dawson, Prosanto Chaudhury, Robert J. Abraham, Brandon M. Meyers, Gonzalo Sapisochin, David Valenti, Setareh Samimi, Ravi Ramjeesingh, Amol Mujoomdar, Ilidio Martins, Elijah Dixon, Maja Segedi, David M. Liu. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews 2023; 115: 102526 doi: 10.1016/j.ctrv.2023.102526
|
| 10 |
Wen-Bin Duan, Xiao-Hui Wang, Guo-Can Zhang, Zhuo He, Shao-Qiang Li, Jie Zhou. Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis. ImmunoTargets and Therapy 2024; : 247 doi: 10.2147/ITT.S452339
|
| 11 |
Ch. Paganetti, A. Heigl, R. Rosenberg, M. Vetter, J. Haslbauer, M. Steuerwald. Case report: 65-year-old man with metachronous left sided adrenal metastasis of hepatocellular carcinoma. International Journal of Surgery Case Reports 2024; 119: 109683 doi: 10.1016/j.ijscr.2024.109683
|
| 12 |
Rocchina Miglionico, Ilenia Matera, Giovanna Maria Ventola, Giovanna Marchese, Vittorio Abruzzese, Magnus Monné, Angela Ostuni, Faustino Bisaccia. Gene Expression Reprogramming by Citrate Supplementation Reduces HepG2 Cell Migration and Invasion. International Journal of Molecular Sciences 2024; 25(12): 6509 doi: 10.3390/ijms25126509
|
| 13 |
Yang Deng, Zhili Chen, Qiufeng He, Bei Wu, Ting Su, Chuangjie Mao, Rong Hu. Clinical value of systemic immunoinflammatory index in predicting recurrence and metastasis in patients with primary liver cancer. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03749-7
|
| 14 |
Xue-Mei You, Fei-Chen Lu, Fan-Rong Li, Feng-Juan Zhao, Rong-Rui Huo. Dynamics trajectory of patient-reported quality of life and its associated risk factors among hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a prospective cohort study. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1463655
|